Disease burden of 32 infectious diseases in the Netherlands, 2007-2011

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Van Lier, Alies ^a   McDonald, Scott A ^a   Bouwknegt, Martijn ^a   Van Der Sande, Marianne ^a   Bijkerk, Paul ^a   Van Benthem, Birgit ^a   Hahné, Susan ^a   Van Der Hoek, Wim ^a   Van Pelt, Wilfrid ^a   Heijne, Janneke ^a   Van Den Broek, Ingrid ^a   De Coul, Eline Op ^a   Van Der Maas, Nicoline ^a   Brandsema, Petra ^a   Slump, Erika ^a   Knol, Mirjam ^a   Friesema, Ingrid ^a   Brooke, John ^b   Haagsma, Juanita ^b   De Wit, Ardine ^b   Krämer, Alexander ^d   Pinheiro, Paulo ^d   Plaß, Dietrich ^d   Fèvre, Eric ^e   Gibbons, Cheryl ^e   Franco, Elisabetta ^f   Longhi, Silvia ^f   Ricciardi, Walter ^f   De Waure, Chiara ^f   Jahn, Beate ^g   Mühlberger, Nikolai ^g   Siebert, Uwe ^g   Lai, Taavi ^h   Matsi, Ardo ^h   Rüütel, Kristi ^h   Cassini, Alessandro ⁱ   Colzani, Edoardo ⁱ   Kramarz, Piotr ⁱ   Havelaar, Arie ^a,c   Kretzschmar, Mirjam ^a   Mangen, Marie Josée J ^a,b   Erkens, Connie ^j   Swaan, Corrien ^a   Achterberg, Peter ^a   Land, Jolande ^k   Wallinga, Jacco ^a   De Melker, Hester E ^a   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF FLORIDA   (United States)

^d BIELEFELD UNIVERSITY   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^h NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

ⁱ EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^j KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAMPYLOBACTERIOSIS; CHLAMYDIASIS; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DISEASE COURSE; DISEASE SURVEILLANCE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; GIARDIASIS; GONORRHEA; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; INFLUENZA; LEGIONNAIRE DISEASE; LISTERIOSIS; MAJOR CLINICAL STUDY; MEASLES; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; MUMPS; NETHERLANDS; NONHUMAN; NOROVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PUBLIC HEALTH; Q FEVER; RABIES; RUBELLA; SALMONELLOSIS; SHIGELLOSIS; SYPHILIS; TETANUS; TOXOPLASMOSIS; TUBERCULOSIS; VARIANT CREUTZFELDT JAKOB DISEASE; ADULT; AGED; COMMUNICABLE DISEASES; COST OF ILLNESS; ECONOMICS; FEMALE; FOOD; MALE; MIDDLE AGED; RESPIRATORY TRACT DISEASES; SEXUALLY TRANSMITTED DISEASES; VACCINATION; YOUNG ADULT;

ADULT; AGED; COMMUNICABLE DISEASES; COST OF ILLNESS; FEMALE; FOOD; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RESPIRATORY TRACT DISEASES; SEXUALLY TRANSMITTED DISEASES; VACCINATION; YOUNG ADULT;

EID: 84977473014     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153106     Document Type: Article

References (71)

1. Gold MR, Muennig P. Measure-dependent variation in burden of disease estimates: implications for policy. Med Care. 2002; 40(3):260-6. PMID: 11880798
2. Mangen MJJ, Plass D, Kretzschmar MEE. Estimating the current and future burden of communicable diseases in the European Union and EEA/EFTA. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2014 (RIVM report 210474001).
3. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72(3):429-45. PMID: 8062401
4. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994; 72(3):495-509. PMID: 8062404
5. Murray CJL, Lopez AD. The Global Burden of Disease - a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Global burden of disease and injuries series; I). Cambridge: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996.
6. Mathers CD, Vos ET, Stevenson CE, Begg SJ. The burden of disease and injury in Australia. Bull World Health Organ. 2001; 79(11):1076-84. PMID: 11731817
7. Lai T, Habicht J, Kiivet RA. Measuring burden of disease in Estonia to support public health policy. Eur J Public Health. 2009; 19(5):541-7. doi: 10.1093/eurpub/ckp038 PMID: 19401358
8. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197-223. doi: 10.1016/S0140-6736(12) 61689-4 PMID: 23245608
9. Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Muhlberger N, et al. The pathogen-and incidence-based DALY approach: an appropriate methodology for estimating the burden of infectious diseases. PLoS One. 2013; 8(11):e79740. doi: 10.1371/journal.pone.0079740 PMID: 24278167
10. Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, et al. New methodology for estimating the burden of infectious diseases in Europe. PLoS Med. 2012; 9(4):e1001205. doi: 10.1371/journal.pmed.1001205 PMID: 22529750
11. European Centre for Disease Prevention and Control (ECDC). Methodology protocol for estimating burden of communicable diseases. Stockholm: ECDC; 2010.
12. Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM, Verhoef LP, Vijgen SM, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol. 2012; 156(3):231-8. doi: 10. 1016/j.ijfoodmicro.2012.03.029 PMID: 22541392
13. Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014; 59 (3):565-9. doi: 10.1007/s00038-014-0552-z PMID: 24752429
14. Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014; 14(1):147.
15. World Health Organization (WHO). The global burden of disease: 2004 update. Geneva: WHO; 2008.
16. European Centre for Disease Prevention and Control (ECDC). Current and future Burden of Communicable Diseases in the European Union and EEA/EFTA countries (BCoDE) - Update of the methodology protocol. Stockholm: ECDC; 2011.
17. Melse JM, Kramers PGN. Berekening van de ziektelast in Nederland. Achtergronddocument bij VTV-1997 (deel 3, hoofdstuk 7). [Calculations of the burden of disease in the Netherlands. Background report for the Public Health Status and Forecast 1997 (report III, chapter 7)]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 1998 (RIVM report 431501028). Dutch.
18. van Lier A, McDonald S, Bouwknegt M, Bijkerk P, Havelaar A, Kretzschmar M, et al. Disease burden of infectious disease in the Netherlands. In: Bijkerk P, van Lier A, McDonald S, Kardamanidis K, Fanoy EB, Wallinga J, et al., editors. State of infectious diseases in the Netherlands, 2013. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2014 (RIVM report 150205001). Available: http://www.rivm.nl/bibliotheek/rapporten/150205001.pdf.
19. Bijkerk P, van Lier A, McDonald S, Wallinga J, de Melker HE. Appendix: State of infectious diseases in the Netherlands, 2013. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2014 (Appendix RIVM report 150205001). Available: http://www.rivm.nl/bibliotheek/rapporten/appendix150205001.pdf.
20. Haagsma JA, van der Zanden BP, Tariq L, van Pelt W, van Duynhoven YTPH, Havelaar AH. Disease burden and costs of selected foodborne pathogens in the Netherlands, 2006. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2009 (RIVM report 330331001).
21. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012; 380(9859):2063-6. doi: 10.1016/S0140-6736(12)61899-6 PMID: 23245602
22. Cassini A, Colzani E, Lewandowski D, Mangen M-JJ, McDonald S, Plass D, et al. Improving the usability and communication of burden of disease methods and outputs: the experience of the Burden of Communicable Diseases in Europe software toolkit. The Lancet. 2013; 381(Supplement 2):S27.
23. Vose D. Risk analysis: a quantitative guide. Chichester: John Wiley & Sons; 2008.
24. Rahamat-Langendoen J, van Vliet H. Staat van Infectieziekten in Nederland, 2000-2005. [State of Infectious Diseases in the Netherlands, 2000-2005]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2006. (RIVM report 210211003). Dutch.
25. Gommer AM, Poos MJJC, Hoeymans N. Verloren levensjaren, ziekte en ziektelast voor 56 geselecteerde aandoeningen. [Life years lost, morbidity and disease burden for 56 selected disorders]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2010. Dutch [Access Date 28-05-2014]; Available: http://www.nationaalkompas.nl/gezondheid-en-ziekte/sterfte-levensverwachting-endaly-s/ziektelast-in-daly-s/verloren-levensjaren-ziekte-en-ziektelast-voor-56-geselecteerdeaandoeningen/.
26. van den Wijngaard CC, Hofhuis A, Harms M, Haagsma J, Wong A, de Wit A, et al. The Burden of Lyme Borreliosis expressed in Disability-Adjusted Life Years. Eur J Public Health. Manuscript in press.
27. Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, Manuel DG, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One. 2012; 7(9):e44103. doi: 10.1371/journal.pone.0044103 PMID: 22962601
28. Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect. 2014; 142(10):2024-35. doi: 10.1017/S0950268813003312 PMID: 24480146
29. Naghavi M, Abolhassani F, Pourmalek F, Lakeh M, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Popul Health Metr. 2009; 7:9. doi: 10.1186/1478-7954-7-9 PMID: 19527516
30. Australian Institute of Health and Welfare, Begg S, Vos T, Barker B, Stevenson C, Stanley L, et al. The burden of disease and injury in Australia 2003. AIHW cat. no. PHE 82. Canberra: Australian Institute of Health and Welfare; 2007.
31. Bradshaw D, Groenewald P, Laubscher R, Nannan N, Nojilana B, Norman R, et al. Initial burden of disease estimates for South Africa, 2000. S Afr Med J. 2003; 93(9):682-8. PMID: 14635557
32. Public Health Group. Victorian Burden of Disease Study. Mortality and morbidity in 2001. Melbourne Victoria: Public Health Group, Rural and Regional Health and Aged Care Services Division. Victorian Government Department of Human Services; 2005.
33. McKenna MT, Michaud CM, Murray CJ, Marks JS. Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med. 2005; 28(5):415-23. PMID: 15894144
34. Jankovic S, Vlajinac H, Bjegovic V, Marinkovic J, Sipetic-Grujicic S, Markovic-Denic L, et al. The burden of disease and injury in Serbia. Eur J Public Health. 2007; 17(1):80-5. PMID: 16751634
35. Mokdad AH, Jaber S, Aziz MI, AlBuhairan F, AlGhaithi A, AlHamad NM, et al. The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014; 383(9914):309-20. doi: 10.1016/S0140-6736(13)62189-3 PMID: 24452042
36. Bundhamcharoen K, Odton P, Phulkerd S, Tangcharoensathien V. Burden of disease in Thailand: changes in health gap between 1999 and 2004. BMC Public Health. 2011; 11:53. doi: 10.1186/1471-2458-11-53 PMID: 21266087
37. Plass D, Vos T, Hornberg C, Scheidt-Nave C, Zeeb H, Krämer A. Trends in disease burden in Germany: results, implications and limitations of the Global Burden of Disease study. Dtsch Arztebl Int. 2014; 111(38):629-38. doi: 10.3238/arztebl.2014.0629 PMID: 25316518
38. Hahné S, van Houdt R, Koedijk F, van Ballegooijen M, Cremer J, Bruisten S, et al. Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands. PLoS One. 2013; 8(7): e67866. doi: 10.1371/journal.pone.0067866 PMID: 23922651
39. Soetens LC, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, van Aar F, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2012. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2013. (RIVM report 150002003).
40. Evaluation team RIVM. Chlamydia Screening Implementation Netherlands. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2010. (RIVM report 210261008).
41. Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, et al. Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates. PLoS One. 2013; 8(3):e58674. doi: 10.1371/journal.pone.0058674 PMID: 23527005
42. de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, et al. Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated registerbased implementation study in the Netherlands. Sex Transm Infect. 2015.
43. Abbink F, de Greeff SC, van den Hof S, de Melker HE. Het Rijksvaccinatieprogramma in Nederland: het vóórkomen van de doelziekten (1997-2002). [The National Immunization Programme in the Netherlands: the occurrence of targetdiseases (1997-2002)]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2004 (RIVM-report 210021001). Dutch.
44. van den Hof S, Conyn-van Spaendonck MAE, de Melker HE, Geubbels ELPE, Suijkerbuijk AWM, Talsma E, et al. The effects of vaccination, the incidence of the target diseases. Bilthoven: National Institute for Public Health and the Environment (RIVM); 1998 (RIVM-report 213676008).
45. Kramer MA, de Greeff SC, Hahné SJM, de Melker HE. Morbiditeit en mortaliteit van ziekten uit het Rijksvaccinatieprogramma, 1997-2006. [Morbidity and mortality of diseases in the National Immunisation Programme, 1997-2006]. Infectieziekten Bulletin. 2008; 19(5):161-3. Dutch.
46. van Lier EA, Oomen PJ, Oostenbrug MW, Zwakhals SL, Drijfhout IH, de Hoogh PA, et al. Hoge vaccinatiegraad van het Rijksvaccinatieprogramma in Nederland. [High vaccination coverage of the National Immunization Programme in the Netherlands]. Ned Tijdschr Geneeskd. 2009; 153(20):950-7. Dutch. PMID: 19490720
47. van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine. 2013; 31(41):4541-7. doi: 10.1016/j.vaccine.2013.07.060 PMID: 23933365
48. Statistics Netherlands (CBS). Deaths by main primary cause of death, sex and age. Voorburg: CBS; 2007-2011.
49. Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch Dis Child. 2002; 86(5):336-8. PMID: 11970924
50. van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis. 2012; 18(11):1729-37. doi: 10.3201/eid1811.120329 PMID: 23092683
51. van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis. 2001; 7(3 Suppl):593-7. PMID: 11485681
52. Hahné S, Ward M, Abbink F, van Binnendijk R, Ruijs H, van Steenbergen J, et al. Large ongoing rubella outbreak in religious community in the Netherlands since September 2004. Euro Surveill. 2005; 10(3): E0503032.
53. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, Fanoy E, et al. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill. 2008; 13(24).
54. Knol M, Urbanus A, Swart E, Mollema L, Ruijs W, van Binnendijk R, et al. Large ongoing measles outbreak in a religious community in the Netherlands since May 2013. Euro Surveill. 2013; 18(36):pii = 20580. PMID: 24079377
55. van der Hoek W, Hogema BM, Dijkstra F, Rietveld A, Wijkmans CJ, Schneeberger PM, et al. Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. Euro Surveill. 2012; 17(3):20058. PMID: 22297100
56. von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis. 2008; 46(9):1356-64. doi: 10.1086/586741 PMID: 18419436
57. Schneeberger PM, Dorigo-Zetsma JW, van der Zee A, van Bon M, van Opstal JL. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand J Infect Dis. 2004; 36(4):269-73. PMID: 15198183
58. Braun JJ, de Graaff CS, de Goey J, Zwinderman AH, Petit PL. Buiten het ziekenhuis opgelopen pneumonie: verwekkers en beloop bij patiënten opgenomen in een algemeen ziekenhuis. [Communityacquired pneumonia: pathogens and course in patients admitted to a general hospital]. Ned Tijdschr Geneeskd. 2004; 148(17):836-40. Dutch. PMID: 15141651
59. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997; 337(10):682-7. PMID: 9278466
60. Beaute J, Zucs P, de Jong B. Risk for travel-associated legionnaires' disease, Europe, 2009. Emerg Infect Dis. 2012; 18(11):1811-6. doi: 10.3201/eid1811.120496 PMID: 23092591
61. Beaute J, Robesyn E, de Jong B, European Legionnaires' Disease Surveillance Network. Legionnaires' disease in Europe: all quiet on the eastern front? Eur Respir J. 2013; 42(6):1454-8. doi: 10.1183/09031936.00089113 PMID: 24293418
62. Beaute J, Zucs P, de Jong B, European Legionnaires' Disease Surveillance Network. Legionnaires disease in Europe, 2009-2010. Euro Surveill. 2013; 18(10):20417. PMID: 23515061
63. Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al. Dutch Guidelines on the Management of Community-Acquired Pneumonia in Adults. Nijmegen: The Dutch Working Party on Antibiotic Policy (SWAB)/Dutch Association of Chest Physicians (NVALT); 2011.
64. Brandsema PS, Euser SM, Karagiannis I, den Boer JW, van der Hoek W. Summer increase of Legionnaires' disease 2010 in The Netherlands associated with weather conditions and implications for source finding. Epidemiol Infect. 2014; 142(11):2360-71. doi: 10.1017/S0950268813003476 PMID: 24576486
65. Karagiannis I, Brandsema P, M VDS. Warm, wet weather associated with increased Legionnaires' disease incidence in The Netherlands. Epidemiol Infect. 2009; 137(2):181-7. doi: 10.1017/S095026880800099X PMID: 18631425
66. Slump E, Erkens CGM, van Hunen R, van Rest JF, Schimmel HJ, van Soolingen D. Tuberculose in Nederland 2011: surveillancerapport. [Tuberculosis in the Netherlands 2011: surveillance report]. the Hague: KNCV Tuberculosefonds; 2012. Dutch.
67. European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2012. Stockholm: ECDC; 2012.
68. Lobue P, Menzies D. Treatment of latent tuberculosis infection: An update. Respirology. 2010; 15 (4):603-22. doi: 10.1111/j.1440-1843.2010.01751.x PMID: 20409026
69. Bouwknegt M, van Pelt W, Havelaar AH. Scoping the impact of changes in population age-structure on the future burden of foodborne disease in the Netherlands, 2020-2060. Int J Environ Res Public Health. 2013; 10(7):2888-96. doi: 10.3390/ijerph10072888 PMID: 23851976
70. McDonald SA, van Lier A, Plass D, Kretzschmar ME. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. BMC Public Health. 2012; 12:1046. doi: 10.1186/1471-2458-12-1046 PMID: 23217094
71. Devleesschauwer B, Maertens de Noordhout C, Smit GS, Duchateau L, Dorny P, Stein C, et al. Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints. BMC Public Health. 2014; 14(1):1196.